Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease

High-density lipoproteins (HDL) comprise a heterogeneous family of lipoprotein particles divided into subclasses that are determined by density, size and surface charge as well as protein composition. Epidemiological studies have suggested an inverse correlation between High-density lipoprotein-chol...

Full description

Bibliographic Details
Main Authors:	Diego Estrada-Luna, María Araceli Ortiz-Rodriguez, Lizett Medina-Briseño, Elizabeth Carreón-Torres, Jeannett Alejandra Izquierdo-Vega, Ashutosh Sharma, Juan Carlos Cancino-Díaz, Oscar Pérez-Méndez, Helen Belefant-Miller, Gabriel Betanzos-Cabrera
Format:	Article
Language:	English
Published:	MDPI AG 2018-10-01
Series:	Molecules
Subjects:	lipoproteins HDL-C paraoxonase polyphenols
Online Access:	https://www.mdpi.com/1420-3049/23/11/2730

Similar Items

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019-01-01)

Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01)

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity
by: Amirnader Emami Razavi, et al.
Published: (2012-01-01)

Atividade da paraoxonase / aril-esterase (PON) e incorporação de fosfolipídeos em partículas de HDL na hipertrigliceridemia humana
by: Vieira, Marcos Soares
Published: (2013)

Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), while Glycated HDL Lost the Antiviral Activity
by: Kyung-Hyun Cho, et al.
Published: (2021-02-01)

Antioxidant properties of HDL
by: Handrean eSoran, et al.
Published: (2015-10-01)

Serum Lipid Profiles, Relationship Between Paraoxonase/Arylesterase Activity and High-density Lipoprotein Levels in Patients with Migraine
by: Yasemin Eren, et al.
Published: (2017-09-01)

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism
by: Huibi Cao, et al.
Published: (1999-01-01)

Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
by: James P. Corsetti, et al.
Published: (2019-09-01)

Influência da obesidade em adolescentes sobre a atividade da paraoxonase (PON1) e o tamanho da Lipoproteína de Alta Densidade (HDL)
by: Claudia Assef Sanibal
Published: (2012)

Influência da obesidade em adolescentes sobre a atividade da paraoxonase (PON1) e o tamanho da Lipoproteína de Alta Densidade (HDL)
by: Sanibal, Claudia Assef
Published: (2012)

Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension
by: You-Cheol Hwang, et al.
Published: (2018-09-01)

Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
by: Beekhof Piet K, et al.
Published: (2012-05-01)

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
by: Philip J. Barter
Published: (2013-09-01)

Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
by: Amirnader Emami Razavi, et al.
Published: (2013-06-01)

Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
by: Amirnader Emami Razavi, et al.
Published: (2013-06-01)

Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients
by: Muzaffer Eroglu, et al.
Published: (2013-07-01)

The contribution of paraoxonase 1 and myeloperoxidase to HDL-cholesterol functionality
by: Malara Marzena, et al.
Published: (2016-05-01)

High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
by: Knut Tore Lappegård, et al.
Published: (2021-07-01)

High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
by: Andrea Bonnin Márquez, et al.
Published: (2020-11-01)

Pomegranate for Your Cardiovascular Health
by: Michael Aviram, et al.
Published: (2013-04-01)

To Study the Activity of Paraoxonase-1 and High Density Lipoprotein-Cholesterol in Alcoholic Liver Cirrhosis
by: Pooja Nemagoudar, et al.
Published: (2017-01-01)

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender
by: Hamit Yasar Ellidag, et al.
Published: (2016-12-01)

Baculovirus-mediated expression and purification of human serum paraoxonase 1A
by: Robert J. Brushia, et al.
Published: (2001-06-01)

The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status
by: Laura S. Rozek, et al.
Published: (2005-09-01)

Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity
by: Idoia Genua, et al.
Published: (2021-04-01)

In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
by: Catherine C. Hedrick, et al.
Published: (2001-04-01)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
by: Alice Ossoli, et al.
Published: (2016-06-01)

Fluorometric sedimentation equilibrium for lipoprotein sub-class analysis.
by: Henriquez, Ronald Rene
Published: (2010)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
by: Xinbo Zhang, et al.
Published: (2018-09-01)

Cardiovascular risk in carotid disease: assessment of doppler sonography and biomarker results Risco cardiovascular e doença carotídea: avaliação de resultados de doppler e biomarcadores
by: Rogério Jorge Barbosa de Oliveira, et al.
Published: (2013-02-01)

Impact of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio on the risk factors for and outcome of ischemic stroke
by: Xin-wei BI, et al.
Published: (2014-10-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)

A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins
by: Ming Ding, et al.
Published: (2020-04-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

Probucol alleviates atherosclerosis and improves high density lipoprotein function
by: Zhong Jian-Kai, et al.
Published: (2011-11-01)

Características fenotípicas e funcionais da lipoproteína de alta densidade (HDL) na hipoalfalipoproteinemia e na aterosclerose subclínica = Phenotypical and functional characteristics of high-density lipoprotein (HDL) on hypoalphalipoproteinemia or subclinical atherosclerosis
by: Panzoldo, Natália Baratella, 1987-
Published: (2014)

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy
by: Elisabet Rodríguez-Tomàs, et al.
Published: (2019-07-01)

High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions
by: Athina Trakaki, et al.
Published: (2020-12-01)

The role of high density lipoprotein compositional and functional heterogeneity in metabolic disease
by: Gordon, Scott M.
Published: (2012)